NCOA2, nuclear receptor coactivator 2, 10499

N. diseases: 95; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.050 Biomarker disease BEFREE These data indicate that MOZ-TIF2/BRPF1 complex upregulates HOX genes mediated by MOZ-dependent histone acetylation, leading to the development of leukemia. 24258712 2014
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.050 Biomarker disease BEFREE Moreover, induction of AML was suppressed in CSF1R-deficient mice and CSF1R inhibitors slowed the progression of MOZ-TIF2-induced leukemia. 20418886 2010
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.050 Biomarker disease BEFREE In addition, ETV6-NCOA2 leukemia shows a high frequency of heterozygous activating NOTCH1 mutations, which disrupt the heterodimerization or the PEST domains. 18281529 2008
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.050 Biomarker disease BEFREE Although leukemia-derived fusion proteins such as MOZ-TIF2 promote self-renewal of leukemic stem cells, recent studies indicate that murine MOZ and MORF are important for proper development of hematopoietic and neurogenic progenitors, respectively, thereby highlighting the importance of epigenetic integrity in safeguarding stem cell identity. 17694082 2007
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.050 GeneticVariation disease BEFREE This similarity is also apparent at the molecular genetic level, in-as-much as the MOZ gene in 8p11 is rearranged in both the translocation and the inversion; in t(8;16)-positive leukemia, a MOZ-CBP chimeric gene is generated, whereas inv(8) has been shown to generate a MOZ-TIF2 fusion gene. 11342350 2000